Sam Morris

Urology Registrar at Imperial College London NHS Trust; Clinical Research Fellow for IP-10 AVIDITY; GKT/KCL Class of 2020; MBBS BSc MRCS

[Sam Morris @_Sam_Morris_]

Further #AUA2026 highlights with the @IP_London team in a very sunny Washington DC:

- Presenting #AVIDITY in the Trial in Progress session

- Air conditioned IP

- IP melting

- Robotic candy floss!

[Sam Morris @_Sam_Morris_]

Delighted to have been awarded Best Poster at #AUA2026 presenting @IP_London #ATLANTA trial complete pathological response pilot data on behalf of the investigators. Full trial results due early 2027.

[Imperial Prostate @IP_London]

As the #NationalScreeningCommittee recommends against whole population screening in today's announcement, read our survey on the views of UK urologists on #ProstateCancer #Screening here: https://t.co/LmMjcAw3oe

[Imperial Prostate @IP_London]

A superb time for the Imperial Prostate team at #AUA26, with 1️⃣9️⃣ presentations from 5️⃣ fellows spanning screening, imaging, focal therapy, prostatectomy & oligometastatic disease! @Archana_GK1 @AJWLight @NikhilMayor @kalpitha_reddy @_Sam_Morris_

See you in San Diego in 2027!

[Sam Morris @_Sam_Morris_]

Huge thanks to @CR_UK for publishing a summary of the @IP_London #IP10AVIDITY RCT!

https://t.co/At6vRMOUQV

[Sam Morris @_Sam_Morris_]

Amazing from @AJWLight raising money for @prost8uk

[Alexander Light @AJWLight]

Hello! I will be running the @LondonMarathon tomorrow on behalf of @prost8uk, a fantastic charity doing great work to improve prostate cancer treatment within the UK

Any last minute donations would be much appreciated! 🙏

https://t.co/YfBQABOvzl

[Imperial Prostate @IP_London]

Well done to the IP10-AVIDITY Trial team for recruitment hitting double figures! Welcome to @ChelwestFT & @WestMidHospital who have joined as Participation Identification Centres. Shortly opening at @royalmarsdenNHS & @UHSFT to investigate the clinical utility of staging PSMA PET

[Sam Morris @_Sam_Morris_]

@Archana_GK1 👏

[Imperial Prostate @IP_London]

🚨NEW PUBLICATION🚨
IP9-ATLAS protocol now live in Contemporary Clinical Trials!

@NIHRresearch HTA-funded RCT in prostate cancer: Can MRI detect progression earlier than NICE-guided standard of care active surveillance over 5 years?

📄Read it free: https://t.co/ZAvjz3VOxX

[Imperial Prostate @IP_London]

Mr Martin Connor (@Connor_Urol ), Prof. Hashim Ahmed (@LondonProstate1) and patient rep Robert Oldroyd presented the now open #AVIDITY trial which aims to fulfil the need for Level 1 evidence for the clinical utility of PSMA PET/CT in staging high-risk prostate cancer

[ProstateUK Profs @ProstateUKProfs]

@AdamSharpMedOnc @ProstateUK @harveerdev @rcgp @Heer_Lab @NikhilMayor @IP_London Sue’s husband was diagnosed with #ProstateCancer at 52.

After running out of licensed treatment options, he joined a Phase 3 abiraterone trial that extended his life and improved his quality of life.

It inspired Sue’s passion for research, early diagnosis and better treatment.

[Imperial Prostate @IP_London]

We’re at @ProstateUK’s second From Ideas to Innovation @rcgp today.

@NikhilMayor and @Heer_Lab updating the audience on TRANSFORM and TRANSFORM Discovery

[Imperial Prostate @IP_London]

We had an amazing day at the London Landmarks Half Marathon yesterday! 🏃🏽‍♀️🏃🏽‍♂️

The @IP_London Run Club was proud to support @prost8uk!

We’re so close to our fundraising goal - help us get over the line!: https://t.co/j5A1H2F39G

Thank you for all the support! ❤️💙

[Sam Morris @_Sam_Morris_]

The @IP_London team ran the @LLHalf yesterday and raised well over £3000 for @prost8uk 💪

@AJWLight 📷
@Archana_GK1
And many more!

[Sam Morris @_Sam_Morris_]

Delighted to have opened the IP10-AVIDITY trial funded by @ProstateUK , linked to my PhD fellowship @IP_London under the guidance of @LondonProstate1 and @Connor_Urol

#AVIDITY

[Imperial Prostate @IP_London]

📣 The IP10-AVIDITY trial is open!

Funded by @ProstateUK, it randomises patients with high-risk prostate cancer to conventional staging and treatment vs PSMA PET and intensified treatment.

6 patients recruited to date 👏

@LondonProstate1
@Connor_Urol
@_Sam_Morris_
#AVIDITY

[Joseph Norris @MrJosephNorris]

Focal prostate HIFU 🎯

What an honour, privilege & pleasure to now re-join the renowned Imperial Prostate team @IP_London team as Hons Consultant Urological Surgeon & deliver focal therapy!

Very grateful to have been welcomed back warmly, and to help give best possible outcomes for our patients

@ImperialSandC
@ImperialNHS
@FocalSociety
@UkFocal
@LondonProstate1
@TaimurShah

[Imperial Prostate @IP_London]

Day 4 of #EAU26 belongs to our PhD student @AJWLight who presented 7 abstracts! Starting with some much needed 10-year focal therapy outcome data from the #HEAT and #ICE registries 🔥❄️

[Imperial Prostate @IP_London]

Can primary tumour response dictate need to treat primary tumour in new mHSPC diagnoses?

@Archana_GK1 - personalised treatment on the horizon possible from the internal pilot of #IP2ATLANTA, highlighting interesting changes response. Main trial results 2027 #EAU26

@Connor_Urol

[Imperial Prostate @IP_London]

Using data from #IP8FLUORESCE and #LaserSAFE, @NikhilMayor presents our development and validation of a deep learning tool for detecting positive margins during RARP using fluorescence confocal microscopy - highly accurate results! #EAU26

[Imperial Prostate @IP_London]

Another beautiful day in London and an exciting agenda for @IP_London at #EAU26 Day Three! ☀️

@LondonProstate1 @NikhilMayor @Archana_GK1

[Imperial Prostate @IP_London]

#IP2ATLANTA pilot data being presented by @_Sam_Morris_ #EAU26

Local treatment (ablation > radical treatment) potentially improves urinary symptoms in de novo metastatic prostate cancer - the full study results are due Q1 2027